# Filing Detail

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950170-24-025088
Filing Date
2024-03-05
Accepted
2024-03-04 18:14:09
Documents
100
Period of Report
2023-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K/A | inva-20231231.htm iXBRL | 10-K/A | 3162226
2 | EX-23.1 | inva-ex23_1.htm | EX-23.1 | 2539
3 | EX-31.1 | inva-ex31_1.htm | EX-31.1 | 13665
4 | EX-31.2 | inva-ex31_2.htm | EX-31.2 | 13004
5 | EX-32 | inva-ex32.htm | EX-32 | 14271
| Complete submission text file | 0000950170-24-025088.txt |  | 17271529

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | inva-20231231.xsd | EX-101.SCH | 2728081
102 | EXTRACTED XBRL INSTANCE DOCUMENT | inva-20231231_htm.xml | XML | 3561759

Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

EIN.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-30319 | Film No.: 24717025
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)